EGFR定量与乳腺癌生物学特征关系的探讨
被引量：1
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2004年第24期1419-1420,共2页
Chinese Journal of Clinical Oncology
基金
国家自然科学基金资助(编号:30000045)
参考文献9
-
1Tovey SM, Witton CJ, Bartlett JM, et al. Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labeling[J]. Breast Cancer Res, 2004, 6(3):246～251
-
2Trihia H, Murray S, Price K, et al. Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors-a surrogate marker?[J] Cancer,2003, 97(5):1321～1331
-
3Francisco JS, Moraes HP, Dias EP. Evaluation of the Image-Pro Plus 4.5 software for automatic counting of labeled nuclei by PCNA immunohistochemistry [J]. Pesqui Odontol Bras, 2004, 18(2):100-104
-
4Bomfim Ade S, Mandarim-de-Lacerda CA. Enalapril alters the formation of the collagen matrix in spontaneously hypertensive rats[J]. Arq Bras Cardiol, 2003, 81(1):69-72
-
5Nicholson RI, Hutcheson IR, Harper ME, et al. Modulation of epidermal growth factor receptor in endocrine-resistant, estrogen-receptor-positive breast cancer [J]. Ann N Y Acad Sci, 2002,963:104-115
-
6Ariazi EA, Clark GM, Mertz JE. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer[J].Cancer Res, 2002, 62(22):6510～6518
-
7Solbach C, Roller M, Ahr A, et al. Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer [J]. Int J Cancer, 2002, 101(4):390-394
-
8Tsutsui S, Ohno S, Murakami S, ct al. Prognostic significance of the combination of biological parameters in breast cancer [J]. Surg Today, 2003, 33(2):151-154
-
9Lotz M, Wang HH, Cance W, et al. Epidermal growth factor stimulation can substitute for c-Src overexpression in promoting breast carcinoma invasion[J].J Surg Res, 2003, 109(2): 123-129
同被引文献3
-
1孙廷谊,谢红建,孔令非.GS试剂在病理自动化染色中的应用[J].诊断病理学杂志,2013,20(4):254-254. 被引量：3
-
2黄锐.定量病理技术对腋淋巴结阴性乳腺癌患者预后的评估探讨[J].医学美学美容（中旬刊）,2015,24(2):40-40. 被引量：4
-
3徐卫云,陈立,何生,李云春,杨永红,王安群,谢刚.定量病理技术对腋淋巴结阴性乳腺癌患者预后的判断[J].中华肿瘤杂志,2003,25(5):461-463. 被引量：3
-
1黄锐.定量病理技术对腋淋巴结阴性乳腺癌患者预后的评估探讨[J].医学美学美容（中旬刊）,2015,24(2):40-40. 被引量：4
-
2徐卫云,陈立,何生,李云春,杨永红,王安群,谢刚.定量病理技术对腋淋巴结阴性乳腺癌患者预后的判断[J].中华肿瘤杂志,2003,25(5):461-463. 被引量：3
-
3翁晓蓉.浅析定量病理技术在诊断腋淋巴结阴性乳腺癌方面的应用价值[J].当代医药论丛,2016,14(13):123-124. 被引量：3
-
4马锴,朱炎,钟滨.CD44V6与部分涎腺肿瘤临床病理的相关性分析[J].口腔颌面外科杂志,2006,16(4):317-320. 被引量：1
-
5韩方海,孙国锋.大肠癌和脉管侵袭的关系[J].实用肿瘤学杂志,1999,13(2):157-159.
-
6韩方海,吴凌云.大肠癌和脉管侵袭的关系[J].大肠肛门病外科杂志,1998,4(4):50-53. 被引量：1
-
7食管、贲门[J].中国癌症防治杂志,1994(2):117-123.
-
8韩方海,吴凌云,张新民.大肠癌脉管侵袭的临床意义[J].中华普通外科杂志,1997,12(6):372-373. 被引量：1
-
9邵淑丽,赵瑞霞,王全红,张文丽,程琪辉.宫颈鳞癌脉管侵袭数与盆腔淋巴结转移的相关性[J].中华肿瘤杂志,2001,23(2):146-147.
-
10侯建丽,李彪,于兴芳.定量病理技术对腋淋巴结阴性乳腺癌患者治疗的疗效分析[J].世界最新医学信息文摘,2015,0(73):47-47. 被引量：3
